TrialCancer research and treatment2017

Efficacy and Safety of First-Line Necitumumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in East Asian Patients with Stage IV Squamous Non-small Cell Lung Cancer: A Subgroup Analysis of the Phase 3, Open-Label, Randomized SQUIRE Study.

Keunchil Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.